CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

HHS lays groundwork for new FDA rule on releasing the CRLs

RegulatoryNeutral
AI Analysis

Summary

The Trump administration is directing the FDA to formalize a policy for proactively releasing complete response letters (CRLs) to pharmaceutical companies. The rulemaking would codify details of this public disclosure policy.

Importance:4/10
Sentiment:
0.00
FDA_policyCRL_disclosureregulatory_transparencyrulemaking

Read the original article

Published by Endpoints News on July 8, 2026 4:04 PM

Read Original